These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 37349537)

  • 21. Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD.
    Liu H; Zheng D; Lin Y; Liu Z; Liang Z; Su J; Chen R; Zhou H; Wang Z
    Pharmacol Res; 2020 Oct; 160():105095. PubMed ID: 32730904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease Hospitalizations.
    Leitao Filho FS; Alotaibi NM; Ngan D; Tam S; Yang J; Hollander Z; Chen V; FitzGerald JM; Nislow C; Leung JM; Man SFP; Sin DD
    Am J Respir Crit Care Med; 2019 May; 199(10):1205-1213. PubMed ID: 30376356
    [No Abstract]   [Full Text] [Related]  

  • 23. Sputum Microbiome Dynamics in Chronic Obstructive Pulmonary Disease Patients during an Exacerbation Event and Post-Stabilization.
    López Caro JC; Santibáñez M; García Rivero JL; Villanueva M; Sainz J; González Astorqui P; Hierro M; Rodríguez Porres M; Paras Bravo P; Mira A; Rodriguez JC; Galiana A;
    Respiration; 2019; 98(5):447-454. PubMed ID: 31437842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung microbiome dynamics in COPD exacerbations.
    Wang Z; Bafadhel M; Haldar K; Spivak A; Mayhew D; Miller BE; Tal-Singer R; Johnston SL; Ramsheh MY; Barer MR; Brightling CE; Brown JR
    Eur Respir J; 2016 Apr; 47(4):1082-92. PubMed ID: 26917613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistome analyses of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of target genes.
    Ramsheh MY; Haldar K; Bafadhel M; George L; Free RC; John C; Reeve NF; Ziegler-Heitbrock L; Gut I; Singh D; Mistry V; Tobin MD; Oggioni MR; Brightling C; Barer MR
    Thorax; 2020 Jan; 75(1):8-16. PubMed ID: 31699806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease.
    Dicker AJ; Crichton ML; Pumphrey EG; Cassidy AJ; Suarez-Cuartin G; Sibila O; Furrie E; Fong CJ; Ibrahim W; Brady G; Einarsson GG; Elborn JS; Schembri S; Marshall SE; Palmer CNA; Chalmers JD
    J Allergy Clin Immunol; 2018 Jan; 141(1):117-127. PubMed ID: 28506850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The contribution of respiratory microbiome analysis to a treatable traits model of care.
    Taylor SL; O'Farrell HE; Simpson JL; Yang IA; Rogers GB
    Respirology; 2019 Jan; 24(1):19-28. PubMed ID: 30282116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.
    Einarsson GG; Comer DM; McIlreavey L; Parkhill J; Ennis M; Tunney MM; Elborn JS
    Thorax; 2016 Sep; 71(9):795-803. PubMed ID: 27146202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung microbiome mediates the progression from chronic obstructive pulmonary disease to lung cancer through inflammation.
    Wang YJ; Wu SS; Chu J; Kong XY
    Yi Chuan; 2021 Jan; 43(1):30-39. PubMed ID: 33509772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the Lung Microbiome in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
    Wang L; Hao K; Yang T; Wang C
    Chin Med J (Engl); 2017 Sep; 130(17):2107-2111. PubMed ID: 28741603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations.
    Sun Z; Zhu QL; Shen Y; Yan T; Zhou X
    Kaohsiung J Med Sci; 2020 Feb; 36(2):107-113. PubMed ID: 31782610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The sputum microbiome associated with different sub-types of AECOPD in a Chinese cohort.
    Wang J; Chai J; Sun L; Zhao J; Chang C
    BMC Infect Dis; 2020 Aug; 20(1):610. PubMed ID: 32811432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.
    Ghebre MA; Pang PH; Diver S; Desai D; Bafadhel M; Haldar K; Kebadze T; Cohen S; Newbold P; Rapley L; Woods J; Rugman P; Pavord ID; Johnston SL; Barer M; May RD; Brightling CE
    J Allergy Clin Immunol; 2018 Jun; 141(6):2027-2036.e12. PubMed ID: 29709671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiome in Chronic Obstructive Pulmonary Disease: Role of Natural Products Against Microbial Pathogens.
    Santoro A; Tomino C; Prinzi G; Cardaci V; Fini M; Macera L; Russo P; Maggi F
    Curr Med Chem; 2020; 27(18):2931-2948. PubMed ID: 31838985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic obstructive pulmonary disease secondary to household air pollution.
    Assad NA; Balmes J; Mehta S; Cheema U; Sood A
    Semin Respir Crit Care Med; 2015 Jun; 36(3):408-21. PubMed ID: 26024348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Occupational exposure to respiratory irritants and chronic obstructive pulmonary disease].
    Quintavalle S; Mazzetti L; Zeni E; Lo Cascio N; Leprotti S; Ballerin L; Potena A; Mapp CE; De Rosa E; Boschetto P
    G Ital Med Lav Ergon; 2005; 27(3):370-2. PubMed ID: 16240598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating carbon content in airway macrophages as a biomarker of personal exposure to fine particulate matter and its acute respiratory effects.
    Yin G; Wu X; Wu Y; Li H; Gao L; Zhu X; Jiang Y; Wang W; Shen Y; He Y; Chen C; Niu Y; Zhang Y; Mao R; Zeng Y; Kan H; Chen Z; Chen R
    Chemosphere; 2021 Nov; 283():131179. PubMed ID: 34146873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable
    Su YC; Jalalvand F; Thegerström J; Riesbeck K
    Front Immunol; 2018; 9():2530. PubMed ID: 30455693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cigarette smoking and biomass fuel on lung function and respiratory symptoms in middle-aged adults and the elderly in Guangdong province, China: A cross-sectional study.
    Zheng XY; Li ZL; Li C; Guan WJ; Li LX; Xu YJ
    Indoor Air; 2020 Sep; 30(5):860-871. PubMed ID: 32249960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease.
    Cabrera-Rubio R; Garcia-Núñez M; Setó L; Antó JM; Moya A; Monsó E; Mira A
    J Clin Microbiol; 2012 Nov; 50(11):3562-8. PubMed ID: 22915614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.